Equities

Metropolis Healthcare Ltd

METROPOLIS:NSI

Metropolis Healthcare Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)1,535.40
  • Today's Change-31.55 / -2.01%
  • Shares traded180.64k
  • 1 Year change-44.67%
  • Beta0.6311
Data delayed at least 15 minutes, as of Oct 07 2022 11:29 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Metropolis Healthcare Limited is an India-based diagnostics company that operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The Company has spread its footprint across 20 Indian states and over 210 cities.

  • Revenue in INR (TTM)11.81bn
  • Net income in INR1.73bn
  • Incorporated2000
  • Employees4.53k
  • Location
    Metropolis Healthcare LtdNh-8, Sco No. 30, Sector 15, Part IiGURGAON 122001IndiaIND
  • Phone+91 8 422801801
  • Fax+91 2 256622080
  • Websitehttps://www.metropolisindia.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kovai Medical Center And Hospital Ltd9.04bn928.32m16.53bn4.68k17.81--9.061.8384.8384.83825.70--------1,931,441.00--7.99--9.1471.7069.2110.2710.75--3.69--5.5531.2411.2734.2111.6622.473.71
Marico Kaya Enterprises Ltd-100.00bn-100.00bn24.37bn--------------------------------------------------------------
Thyrocare Technologies Ltd5.52bn1.42bn37.07bn2.12k26.09--21.036.7226.8426.84104.18--------2,609,740.00--22.32--24.9171.9270.9325.5524.43--85.16--71.4419.0514.1155.6732.680.79148.45
Healthcare Global Enterprises Ltd14.80bn693.53m39.79bn5.68k51.74--18.592.695.535.53110.71--------2,605,508.00---3.53---4.9153.7154.583.64-6.06--0.973----38.2114.78127.7718.49-18.05--
Vijaya Diagnostic Centre Ltd4.44bn941.61m47.02bn1.82k50.18--31.3810.599.189.1843.30--------2,442,495.00--------85.71--21.37----7.66----22.75--29.83------
Rainbow Children's Medicare Ltd-100.00bn-100.00bn64.03bn2.54k------------------------------------------------49.80--245.51------
Metropolis Healthcare Ltd11.81bn1.73bn79.58bn4.53k46.28--32.566.7433.5933.59229.76--------2,606,864.00--19.70--25.2376.9674.5914.6716.95--11.00--25.1723.0817.6616.9816.0713.06--
Krishna Institute Of Medical Sciencs Ltd16.73bn3.14bn121.16bn7.82k39.70--29.127.2438.1338.13203.02--------2,140,960.00--9.41--13.2078.9354.0319.7810.01--71.58--0.0024.1323.8265.3359.1811.16--
Aster DM Healthcare Ltd105.44bn5.50bn125.51bn25.81k22.83--9.781.1911.0611.06212.01--------4,085,798.00--3.47--5.2363.5461.495.894.13--3.20----19.1111.57256.0238.89-10.08--
Narayana Hrudayalaya Ltd38.75bn3.76bn146.12bn11.47k38.86--25.973.7718.5318.53190.77--------3,379,805.00--4.22--5.3957.8343.559.723.83--7.35----43.3314.532,490.4632.71----
Fortis Healthcare Ltd57.95bn4.14bn199.46bn2.86k48.11--25.063.445.495.4976.90--------20,255,650.00---0.6178---0.857274.6773.568.52-1.42--6.51----41.874.57605.755.65-4.94--
Dr. Lal PathLabs Ltd19.84bn2.71bn208.68bn4.11k76.97--52.2210.5232.7232.72239.24--------4,826,054.00--18.99--22.9476.2475.5513.8517.17--10.66--32.5232.0118.0018.2517.4155.9731.95
Max Healthcare Institute Ltd39.98bn6.31bn395.53bn4.44k62.73--46.239.896.506.5041.19--------9,011,632.00--------77.93--15.78----7.84----56.97--539.88------
Data as of Oct 07 2022. Currency figures normalised to Metropolis Healthcare Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

21.85%Per cent of shares held by top holders
HolderShares% Held
UTI Asset Management Co. Ltd. (Investment Management)as of 31 Aug 20222.92m5.71%
Grandeur Peak Global Advisors LLCas of 16 Nov 20212.56m5.00%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Aug 20221.87m3.66%
The Vanguard Group, Inc.as of 09 Sep 2022783.89k1.53%
JPMorgan Asset Management (UK) Ltd.as of 31 Aug 2022773.27k1.51%
Manulife Investment Management (Europe) Ltd.as of 31 Aug 2022770.67k1.51%
Capital Research & Management Co. (World Investors)as of 30 Jun 2022438.40k0.86%
Franklin Templeton Asset Management (India) Pvt. Ltd.as of 30 Aug 2022364.28k0.71%
White Oak Capital Partners Pte Ltd.as of 31 Dec 2021353.94k0.69%
Fundsmith LLPas of 30 Jun 2022344.93k0.67%
More ▼
Data from 31 Dec 2021 - 31 Aug 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.